Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
563.00
+3.20 (0.57%)
At close: Aug 8, 2025, 4:00 PM
550.02
-12.98 (-2.31%)
After-hours: Aug 8, 2025, 7:48 PM EDT
Pactiv Evergreen Stock Forecast
Stock Price Forecast
The 21 analysts that cover Pactiv Evergreen stock have a consensus rating of "Buy" and an average price target of $814.52, which forecasts a 44.67% increase in the stock price over the next year. The lowest target is $547 and the highest is $1,175.
Price Target: $814.52 (+44.67%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pactiv Evergreen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 7 | 7 | 6 | 5 |
| Buy | 12 | 12 | 11 | 11 | 11 | 10 |
| Hold | 5 | 4 | 4 | 4 | 4 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 23 | 23 | 23 | 22 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Maintains $600 → $640 | Buy | Maintains | $600 → $640 | +13.68% | Aug 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $754 → $761 | Buy | Maintains | $754 → $761 | +35.17% | Aug 4, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $688 → $695 | Hold | Maintains | $688 → $695 | +23.45% | Aug 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $810 → $815 | Strong Buy | Maintains | $810 → $815 | +44.76% | Aug 4, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $850 | Strong Buy | Maintains | $850 | +50.98% | Jul 23, 2025 |
Financial Forecast
Revenue This Year
13.66B
from 14.20B
Decreased by -3.84%
Revenue Next Year
14.57B
from 13.66B
Increased by 6.65%
EPS This Year
36.10
from 38.34
Decreased by -5.85%
EPS Next Year
40.28
from 36.10
Increased by 11.59%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.9B | 16.5B | 18.0B | ||
| Avg | 13.7B | 14.6B | 16.1B | ||
| Low | 12.2B | 12.6B | 14.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.0% | 20.5% | 23.7% | ||
| Avg | -3.8% | 6.6% | 10.7% | ||
| Low | -14.2% | -7.5% | -2.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 44.47 | 56.21 | 66.61 | ||
| Avg | 36.10 | 40.28 | 49.45 | ||
| Low | 29.78 | 32.28 | 37.92 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.0% | 55.7% | 65.4% | ||
| Avg | -5.8% | 11.6% | 22.8% | ||
| Low | -22.3% | -10.6% | -5.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.